The Cell Adhesion Molecule L1 Interacts with Methyl CpG Binding Protein 2 via Its Intracellular Domain

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Cell adhesion molecule L1 (L1) is crucial for neural functions, and its deficiency is linked to neurological disorders.
• Methyl CpG binding protein 2 (MeCP2) is a key regulator of gene expression in the nervous system.
• The intracellular domain of L1 has been identified as a potential binding partner for MeCP2.

Purpose of the Study:

• To investigate the direct interaction between the intracellular domain of L1 and MeCP2.
• To identify the specific L1 fragment and motif involved in the MeCP2 interaction.
• To elucidate the functional consequences of the MeCP2/L1 interaction on neuronal development and gene expression.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) to confirm direct binding.
• Proximity ligation assay (PLA) to assess cellular association in neurons.
• Immunoprecipitation to identify interacting L1 fragments.
• Small interfering RNA (siRNA) to modulate gene expression.
• Analysis of myocyte enhancer factor 2C (Mef2c) mRNA and protein levels.

Main Results:

• Direct binding between L1's intracellular domain and MeCP2 was confirmed, mediated by the KDET motif.
• A ~55 kDa L1 fragment (L1-55) was found to interact with MeCP2 in neuronal nuclei.
• Metalloproteases BACE1 and ɣ-secretase are implicated in generating L1-55.
• Reduced MeCP2 or L1 expression impaired L1-dependent neurite outgrowth and cell migration.
• The MeCP2/L1 interaction was shown to regulate Mef2c expression.

Conclusions:

• The novel L1 fragment L1-55 interacts with MeCP2, impacting L1-mediated neuronal functions.
• This interaction plays a role in neurite outgrowth, neuronal migration, and Mef2c gene regulation.
• Findings reveal a new molecular mechanism involving L1 and MeCP2 in neural development and disease.